Aim Bulletin

ValiRx losses narrow in first half

By Josh White

Date: Friday 27 Sep 2024

(Sharecast News) - ValiRx, a life science company focussed on cancer therapeutic development, reported a total comprehensive loss of £0.97m for the six months ended 30 June on Friday, narrowing from a loss of £1.04m in the same period last year.

The AIM-traded company said its loss before income tax...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page